✦ LIBER ✦

Personalized therapy for breast cancer

✍ Scribed by De Abreu, F.B.; Schwartz, G.N.; Wells, W.A.; Tsongalis, G.J.

Book ID: 124164043
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 726 KB
Volume: 86
Category: Article
ISSN: 0009-9163
DOI: 10.1111/cge.12381

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Personalized therapy for breast cancer:

Personalized therapy for breast cancer: a dream or a reality?

✍ Zardavas, Dimitrios; Pugliano, Lina; Piccart, Martine 📂 Article 📅 2013 🏛 Future Medicine 🌐 English ⚖ 826 KB

Targeting XRCC1 Deficiency in Breast Can

Targeting XRCC1 Deficiency in Breast Cancer for Personalized Therapy

✍ Sultana, R.; Abdel-Fatah, T.; Abbotts, R.; Hawkes, C.; Albarakati, N.; Seedhouse 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 1006 KB

Hormonal therapy in breast cancer: A mod

Hormonal therapy in breast cancer: A model disease for the personalization of cancer care

✍ Shannon Puhalla; Saveri Bhattacharya; Nancy E. Davidson 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 287 KB

Breast cancer in 2010: Novel targets and

Breast cancer in 2010: Novel targets and therapies for a personalized approach

✍ Higgins, Michaela J.; Baselga, José 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 192 KB

PTPRO promoter methylation is predictive

PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy

✍ Huang, Yi-Teng; Li, Fei-Fei; Ke, Chen; Li, Zhou; Li, Zong-Tai; Zou, Xiao-Fang; Z 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 329 KB

Should menopausal women at increased ris

Should menopausal women at increased risk for breast cancer use tamoxifen, raloxifene, or hormone therapy?: A framework for personalized risk assessment and counseling

✍ Ellent T. Matloff; Kristen M. Shannon; Anne Moyer; Nananda F. Col 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 87 KB